X-linked hypohidrotic ectodermal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:181OMIM:305100Q82.4
Who is this for?
Show terms as
28Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked hypohidrotic ectodermal dysplasia (XLHED), also known as Christ-Siemens-Touraine syndrome, is the most common form of ectodermal dysplasia. It is caused by pathogenic variants in the EDA gene located on the X chromosome, which encodes the protein ectodysplasin A. This protein plays a critical role in the development of ectodermal structures during embryonic life, including hair, teeth, and sweat glands. Because of its X-linked recessive inheritance, males are typically more severely affected, while female carriers may show mild or variable features. The hallmark clinical triad of XLHED includes hypohidrosis (reduced or absent sweating due to fewer or absent eccrine sweat glands), hypotrichosis (sparse, thin, and lightly pigmented scalp and body hair), and hypodontia or oligodontia (missing teeth, with those present often being conical or peg-shaped). The inability to sweat properly can lead to life-threatening hyperthermia, particularly in infants and young children, as the body cannot regulate temperature effectively. Affected individuals may also have characteristic facial features including frontal bossing, a depressed nasal bridge, prominent lips, and periorbital wrinkling and hyperpigmentation. Dry skin, eczema-like rashes, and reduced mucous gland secretions affecting the eyes, airways, and gastrointestinal tract are also common. Currently, management of XLHED is primarily supportive and symptomatic. Temperature regulation strategies are essential, including avoidance of overheating, access to cooling devices, and environmental modifications. Dental management typically involves early prosthetic rehabilitation with dentures or dental implants to improve feeding, speech, and appearance. Artificial tears and nasal saline may be used for dryness of the eyes and airways. An investigational prenatal and neonatal treatment with a recombinant replacement protein (ER004) targeting the EDA pathway has shown promise in clinical trials, but is not yet approved for routine clinical use. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Everted upper lip vermilionHP:0010803Anterior hypopituitarismHP:0000830
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for X-linked hypohidrotic ectodermal dysplasia.

View clinical trials →

No actively recruiting trials found for X-linked hypohidrotic ectodermal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked hypohidrotic ectodermal dysplasia community →

Specialists

Showing 25 of 28View all specialists →
HS
Holm Schneider
Specialist
3 X-linked hypohidrotic ectodermal dysplasia publications
DG
Dorothy K Grange
SAINT LOUIS, MO
Specialist
2 X-linked hypohidrotic ectodermal dysplasia publications
FF
Florian Faschingbauer
Specialist
3 X-linked hypohidrotic ectodermal dysplasia publications
SH
Smail Hadj-Rabia
Specialist
3 X-linked hypohidrotic ectodermal dysplasia publications
MB
Murali Dharan Bashyam
Specialist
2 X-linked hypohidrotic ectodermal dysplasia publications
AC
Ajay Kumar Chaudhary
Specialist
2 X-linked hypohidrotic ectodermal dysplasia publications
AC
Angus Clarke
Specialist
2 X-linked hypohidrotic ectodermal dysplasia publications
DM
Dorothy K Grange, MD
SAINT LOUIS, MO
Specialist
PI on 6 active trials
HM
Holm Schneider, MD
Specialist
PI on 5 active trials
MG
Marlène Guiraud
Specialist
PI on 1 active trial1 X-linked hypohidrotic ectodermal dysplasia publication
JM
James Maynard, MD
Specialist
PI on 2 active trials
KP
Kenneth Huttner, MD, PhD
WALTHAM, MA
Specialist
PI on 2 active trials
OP
Ophir Klein, MD, PhD
WEST HOLLYWOOD, CA
Specialist
PI on 2 active trials
EP
Encarna Navarro, MD, PhD
Specialist
PI on 1 active trial
RM
Ramsey Johnson, MSM
Specialist
PI on 1 active trial
SP
Smail Hadj-Rabia, MD, PhD
Specialist
PI on 1 active trial
LM
Lucie Griffon, MD
Specialist
PI on 1 active trial1 X-linked hypohidrotic ectodermal dysplasia publication
LP
Lisa Moscoso, MD, PhD
SAINT LOUIS, MO
Specialist
PI on 1 active trial
BP
Brigitte Fauroux, MD, PhD
Specialist
PI on 1 active trial
CC
Carrie Milliard, CGC
Specialist
PI on 1 active trial
HL
Haochen Liu
Specialist
1 X-linked hypohidrotic ectodermal dysplasia publication
LS
Lanxin Su
Specialist
1 X-linked hypohidrotic ectodermal dysplasia publication
HL
Hangbo Liu
Specialist
1 X-linked hypohidrotic ectodermal dysplasia publication
JZ
Jinglei Zheng
Specialist
1 X-linked hypohidrotic ectodermal dysplasia publication
HF
Hailan Feng
Specialist
1 X-linked hypohidrotic ectodermal dysplasia publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to X-linked hypohidrotic ectodermal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked hypohidrotic ectodermal dysplasiaForum →

No community posts yet. Be the first to share your experience with X-linked hypohidrotic ectodermal dysplasia.

Start the conversation →

Latest news about X-linked hypohidrotic ectodermal dysplasia

No recent news articles for X-linked hypohidrotic ectodermal dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about X-linked hypohidrotic ectodermal dysplasia

What is X-linked hypohidrotic ectodermal dysplasia?

X-linked hypohidrotic ectodermal dysplasia (XLHED), also known as Christ-Siemens-Touraine syndrome, is the most common form of ectodermal dysplasia. It is caused by pathogenic variants in the EDA gene located on the X chromosome, which encodes the protein ectodysplasin A. This protein plays a critical role in the development of ectodermal structures during embryonic life, including hair, teeth, and sweat glands. Because of its X-linked recessive inheritance, males are typically more severely affected, while female carriers may show mild or variable features. The hallmark clinical triad of XLH

How is X-linked hypohidrotic ectodermal dysplasia inherited?

X-linked hypohidrotic ectodermal dysplasia follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does X-linked hypohidrotic ectodermal dysplasia typically begin?

Typical onset of X-linked hypohidrotic ectodermal dysplasia is neonatal. Age of onset can vary across affected individuals.

Which specialists treat X-linked hypohidrotic ectodermal dysplasia?

25 specialists and care centers treating X-linked hypohidrotic ectodermal dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.